Related Experiment Videos
The chronic consequences of severe sepsis
Claudia F Benjamim1, Cory M Hogaboam, Steven L Kunkel
1Department of Pathology, University of Michigan, Ann Arbor, MI 48109-0602, USA.
Journal of Leukocyte Biology
|October 15, 2003
Summary
Severe sepsis survivors face long-term risks, including increased susceptibility to infections like fungal infections. This study explores the immune changes in the lungs after sepsis that lead to these heightened risks.
Area of Science:
- Immunology
- Critical Care Medicine
- Pathology
Background:
- Severe sepsis causes significant short-term mortality and long-term morbidity.
- Survivors of severe sepsis experience high mortality rates within a year, often due to lung complications.
- The cellular and molecular mechanisms driving long-term sepsis sequelae and lung injury require further investigation.
Purpose of the Study:
- To investigate the long-term consequences of severe sepsis on lung immunity.
- To understand the mechanisms underlying increased susceptibility to secondary infections post-sepsis.
- To identify specific immune alterations in the lungs of sepsis survivors.
Main Methods:
- Utilized a murine model of experimental sepsis induced by cecal ligation and puncture (CLP).
- Assessed the survival rates of sepsis survivors when challenged with a secondary fungal infection at different time points post-CLP.
- Analyzed changes in cytokine expression, Toll-like receptor expression, and lung leukocyte populations in surviving mice.
Main Results:
- Sepsis survivors (60% survival rate post-CLP) exhibited 100% mortality when challenged with fungal infection 3 and 15 days after recovery.
- Increased mortality correlated with altered cytokine profiles and Toll-like receptor expression.
- Significant changes in lung leukocyte populations were observed in sepsis survivors.
Conclusions:
- The lungs of severe sepsis survivors remain susceptible to secondary infections for extended periods.
- Mechanisms include altered inflammatory cytokine and chemokine profiles (e.g., MCP-1, C10), potentially affecting innate immune cells like dendritic cells and macrophages.
- These alterations may contribute to the immunosuppression observed after sepsis, predisposing patients to nosocomial infections.